ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Human medicines European public assessment report (EPAR): Ribavirin Mylan (previously Ribavirin Three Rivers), ribavirin, Hepatitis C, Chronic, Date of authorisation: 10/06/2010, Revision: 10, Status: Authorised
Case Medical Research
◽
10.31525/cmr-1907582
◽
2019
◽
Author(s):
Keyword(s):
Hepatitis C
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
◽
Three Rivers
Download Full-text
Related Documents
Cited By
References
Human medicines European public assessment report (EPAR): IntronA, interferon alfa-2b, Carcinoid Tumor,Leukemia, Hairy Cell,Lymphoma, Follicular,Hepatitis B, Chronic,Hepatitis C, Chronic,Leukemia, Myelogenous, Chronic, BCR-ABL Positive,Melanoma,Multiple Myeloma, Date of authorisation: 09/03/2000, Revision: 31, Status: Authorised
Case Medical Research
◽
10.31525/cmr-39964f
◽
2019
◽
Author(s):
Keyword(s):
Multiple Myeloma
◽
Chronic Hepatitis
◽
Hepatitis C
◽
Hepatitis B
◽
Cell Lymphoma
◽
Interferon Alfa
◽
Hairy Cell
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Vosevi, sofosbuvir / velpatasvir / voxilaprevi, Hepatitis C, Chronic, Date of authorisation: 26/07/2017, Revision: 4, Status: Authorised
Case Medical Research
◽
10.31525/cmr-c4dbb9
◽
2019
◽
Author(s):
Keyword(s):
Hepatitis C
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Viekirax, ombitasvir / paritaprevir / ritonavir, Hepatitis C, Chronic, Date of authorisation: 14/01/2015, Revision: 17, Status: Authorised
Case Medical Research
◽
10.31525/cmr-5ed974
◽
2019
◽
Author(s):
Keyword(s):
Hepatitis C
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): IntronA, interferon alfa-2b, Carcinoid Tumor,Leukemia, Hairy Cell,Lymphoma, Follicular,Hepatitis B, Chronic,Hepatitis C, Chronic,Leukemia, Myelogenous, Chronic, BCR-ABL Positive,Melanoma,Multiple Myeloma, Date of authorisation: 09/03/2000, Revision: 31, Status: Authorised
Case Medical Research
◽
10.31525/cmr-fcd076
◽
2019
◽
Author(s):
Keyword(s):
Multiple Myeloma
◽
Chronic Hepatitis
◽
Hepatitis C
◽
Hepatitis B
◽
Cell Lymphoma
◽
Interferon Alfa
◽
Hairy Cell
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Viekirax, ombitasvir / paritaprevir / ritonavir, Hepatitis C, Chronic, Date of authorisation: 14/01/2015, Revision: 18, Status: Authorised
Case Medical Research
◽
10.31525/cmr-5ee337
◽
2019
◽
Author(s):
Keyword(s):
Hepatitis C
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Rebetol, ribavirin, Hepatitis C, Chronic, Date of authorisation: 06/05/1999, Revision: 34, Status: Authorised
Case Medical Research
◽
10.31525/cmr-5ee330
◽
2019
◽
Author(s):
Keyword(s):
Hepatitis C
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Vosevi, sofosbuvir / velpatasvir / voxilaprevi, Hepatitis C, Chronic, Date of authorisation: 26/07/2017, Revision: 4, Status: Authorised
Case Medical Research
◽
10.31525/cmr-c3f2a5
◽
2019
◽
Author(s):
Keyword(s):
Hepatitis C
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Sovaldi, sofosbuvir, Hepatitis C, Chronic, Date of authorisation: 16/01/2014, Revision: 18, Status: Authorised
Case Medical Research
◽
10.31525/cmr-babd5b
◽
2019
◽
Author(s):
Keyword(s):
Hepatitis C
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Epclusa, sofosbuvir / velpatasvir, Hepatitis C, Chronic, Date of authorisation: 06/07/2016, Revision: 7, Status: Authorised
Case Medical Research
◽
10.31525/cmr-be39b6
◽
2019
◽
Author(s):
Keyword(s):
Hepatitis C
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Human medicines European public assessment report (EPAR): Exviera, dasabuvir, Hepatitis C, Chronic, Date of authorisation: 14/01/2015, Revision: 15, Status: Authorised
Case Medical Research
◽
10.31525/cmr-6036cc
◽
2019
◽
Author(s):
Keyword(s):
Hepatitis C
◽
Assessment Report
◽
European Public
◽
European Public Assessment Report
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close